Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific News Journal.
Press releases published on April 30, 2025
Vietnam Equestrian Club Expands Rider Base by Raising Weight Limits This Summer
EIN Presswire
·
April 30, 2025
DA NANG, HOI AN, VIETNAM, April 29, 2025 /EINPresswire.com/ -- The Vietnam Equestrian Club is excited to announce that they will be expanding their rider base this summer by raising the weight limits for horseback riding. This decision comes after years …
Renowned Leadership Expert Nancy Gunter to Speak at SHRM25 in San Diego
EIN Presswire
·
April 30, 2025
Renowned leadership expert Nancy Gunter will bring actionable insights on Positive Intelligence to SHRM25, helping leaders boost resilience and team success. TULSA, OK, UNITED STATES, April 29, 2025 /EINPresswire.com/ -- Renowned Leadership Expert Nancy …
Integral Metals Reports Preliminary Geomicrobial Results from Burntwood Project, Highlights Biological Pathfinder Potential for REE Exploration
GlobeNewswire
·
April 30, 2025
CALGARY, Alberta, April 30, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) is pleased to announce preliminary results from its 2024 geomicrobial survey at the Burntwood Project in northern …
QKS Group Eyes a Global Top 5 Spot in the Analyst Industry
GlobeNewswire
·
April 30, 2025
Middleton, Massachusetts, April 30, 2025 (GLOBE NEWSWIRE) -- The world of technology research and advisory is entering a new era, and it is experiencing fluctuations that are not just visible on paper, but in how the game is played. Firms using traditional …
Global Uranium Advances Athabasca Basin Exploration with Launch of ZTEM Survey at Astro Project
GlobeNewswire
·
April 30, 2025
CALGARY, Alberta, April 30, 2025 (GLOBE NEWSWIRE) -- Global Uranium Corp. (CSE: GURN | OTC: GURFF | FRA: Q3J) (the "Company" or “Global”) and Cosa Resources Corp. (TSX-V: COSA) (OTCQB: COSAF) (FSE: SSKU) (“Cosa”) are pleased to announce that geophysical …
Vaxart Completes Enrollment in Phase 1 Trial for its Norovirus Oral Pill Vaccine Candidate
GlobeNewswire
·
April 30, 2025
- Topline data expected in mid-2025 - SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that it completed enrollment of its Phase 1 clinical trial evaluating its second-generation oral norovirus …
Actinogen provides pivotal Alzheimer’s trial enrolment update and other business news
GlobeNewswire
·
April 30, 2025
SYDNEY, April 30, 2025 (GLOBE NEWSWIRE) -- Actinogen Medical Limited (ASX: ACW) announces that its Alzheimer’s disease phase 2b/3 trial has now enrolled 60 participants and expects to reach 100 by the end of this quarter. That milestone will trigger an …
XING Mobility Launches BBx48: Industry-First Immersion-Cooled BBU That Rewrites the Rules of Data Center Backup Power
GlobeNewswire
·
April 30, 2025
TAIPEI, Taiwan, April 30, 2025 (GLOBE NEWSWIRE) -- XING Mobility, Taiwan’s pioneering force in immersion-cooled battery systems, today announced a transformational leap in data center backup power with the launch of its BBx48 System—a plug-and-play, …
INNEOVA Holdings Limited Strengthens Engineering Capabilities and Accelerates Growth in Sustainable Solutions with the Acquisition of INNEOVA Engineering Pte. Ltd.
GlobeNewswire
·
April 30, 2025
SINGAPORE, April 30, 2025 (GLOBE NEWSWIRE) -- INNEOVA Holdings Limited (Nasdaq: INEO, "INNEOVA Holdings" or the "Company" or the "Group"), a leading Singapore-based provider of high-quality Original Equipment Manufacturer ("OEM"), third-party branded and …
VCI Global’s High-Growth Fintech Startup Credilab Secures Strategic Investment from Dubai Fund
GlobeNewswire
·
April 30, 2025
KUALA LUMPUR, Malaysia, April 30, 2025 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (“VCI Global” or the “Company”) today announced that its fintech subsidiary, Credilab Sdn Bhd (“Credilab”), a fast-scaling digital lending platform, has secured a …
Appendix 4C – Q3 FY25 Quarterly Cash Flow Report
GlobeNewswire
·
April 30, 2025
Highlights Reported positive topline data for ATH434-201 randomized, double-blind Phase 2 clinical trial in Multiple System Atrophy (MSA) led by robust clinical efficacy Phase 2 data featured in an oral presentation at the American Academy of Neurology …
Context Therapeutics Presents Preclinical and Translational Data for CT-95, a Mesothelin Targeting T Cell Engager, at 2025 AACR Annual Meeting
GlobeNewswire
·
April 30, 2025
Preclinical data demonstrates unique binding location of CT-95 on mesothelin and avoidance of binding to shed mesothelin Data supports ongoing Phase 1 clinical trial for CT-95 PHILADELPHIA, April 30, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“ …
Quoin Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
GlobeNewswire
·
April 30, 2025
ASHBURN, Va., April 30, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a late clinical stage, specialty pharmaceutical company focused on the development and commercialization of therapeutic products that …
Altimmune to Participate in the Citizens Life Sciences Conference
GlobeNewswire
·
April 30, 2025
GAITHERSBURG, Md., April 30, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate in a fireside chat at the Citizens Life …
Stallion Uranium Announces Completion of Ground Gravity Survey over Coyote Target
GlobeNewswire
·
April 30, 2025
VANCOUVER, British Columbia, April 30, 2025 (GLOBE NEWSWIRE) -- Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; FSE: FE0) is pleased to announce the successful completion of a ground gravity survey over its Coyote Target, …
InflaRx to Report First Quarter 2025 Results on May 7, 2025
GlobeNewswire
·
April 30, 2025
JENA, Germany, April 30, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that it will report its first quarter 2025 financial …
WeRide Speeds Smart Logistics Commercialization with First Driverless Road Testing License for Robovan in Guangzhou
GlobeNewswire
·
April 30, 2025
GUANGZHOU, China, April 30, 2025 (GLOBE NEWSWIRE) -- The unveiling ceremony for Guangzhou Nansha District's Autonomous Driving Test Base and Smart Transportation Demonstration Zone was held today in Mingzhu Bay. At the event, WeRide (NASDAQ: WRD), a global …
BioCryst to Present at Upcoming Investor Conferences
GlobeNewswire
·
April 30, 2025
RESEARCH TRIANGLE PARK, N.C., April 30, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the following conferences: Citizens Life Sciences Conference in New York on Thursday, May 8, …
Emerita Files NI 43-101 Technical Report for the IBW Project, Marking a 35% Increase in Total Indicated Resources and a 44% Increase in Total Inferred Resources
GlobeNewswire
·
April 30, 2025
TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- Emerita Resources Corp. (TSX – V: EMO; OTCQB: EMOTF; FSE: LLJA) (the “Company” or “Emerita”) reports that it has filed the independent NI 43-101 compliant technical report for its Iberian Belt West Project (“IBW” …
XORTX Provides Update on FDA Type B Meeting Request
GlobeNewswire
·
April 30, 2025
● XORTX will focus on key steps to advance a NDA filing for Gout indication ● CALGARY, Alberta, April 30, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical …